Compile Data Set for Download or QSAR
Report error Found 595 Enz. Inhib. hit(s) with all data for entry = 6766
TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151959BDBM151959(US8987457, 153)
Affinity DataIC50: 0.0100nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151889BDBM151889(US8987457, 83)
Affinity DataIC50: 0.0100nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151905BDBM151905(US8987457, 99)
Affinity DataIC50: 0.0100nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151989BDBM151989(US8987457, 183)
Affinity DataIC50: 0.0100nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151870BDBM151870(US8987457, 64)
Affinity DataIC50: 0.0100nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151946BDBM151946(US8987457, 140)
Affinity DataIC50: 0.0200nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151947BDBM151947(US8987457, 141)
Affinity DataIC50: 0.0200nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151982BDBM151982(US8987457, 176)
Affinity DataIC50: 0.0200nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151948BDBM151948(US8987457, 142)
Affinity DataIC50: 0.0200nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151977BDBM151977(US8987457, 171)
Affinity DataIC50: 0.0200nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151943BDBM151943(US8987457, 137)
Affinity DataIC50: 0.0200nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151879BDBM151879(US8987457, 73)
Affinity DataIC50: 0.0200nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151945BDBM151945(US8987457, 139)
Affinity DataIC50: 0.0200nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151980BDBM151980(US8987457, 174)
Affinity DataIC50: 0.0200nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151954BDBM151954(US8987457, 148)
Affinity DataIC50: 0.0200nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151990BDBM151990(US8987457, 184)
Affinity DataIC50: 0.0200nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151924BDBM151924(US8987457, 118)
Affinity DataIC50: 0.0200nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151950BDBM151950(US8987457, 144)
Affinity DataIC50: 0.0200nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151952BDBM151952(US8987457, 146)
Affinity DataIC50: 0.0200nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151965BDBM151965(US8987457, 159)
Affinity DataIC50: 0.0200nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151862BDBM151862(US8987457, 56)
Affinity DataIC50: 0.0200nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151864BDBM151864(US8987457, 58)
Affinity DataIC50: 0.0200nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151907BDBM151907(US8987457, 101)
Affinity DataIC50: 0.0200nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151941BDBM151941(US8987457, 135)
Affinity DataIC50: 0.0200nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151901BDBM151901(US8987457, 95)
Affinity DataIC50: 0.0200nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151967BDBM151967(US8987457, 161)
Affinity DataIC50: 0.0200nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151971BDBM151971(US8987457, 165)
Affinity DataIC50: 0.0200nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151839BDBM151839(US8987457, 33)
Affinity DataIC50: 0.0200nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151972BDBM151972(US8987457, 166)
Affinity DataIC50: 0.0200nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151878BDBM151878(US8987457, 72)
Affinity DataIC50: 0.0300nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151944BDBM151944(US8987457, 138)
Affinity DataIC50: 0.0300nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151923BDBM151923(US8987457, 117)
Affinity DataIC50: 0.0300nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151891BDBM151891(US8987457, 85)
Affinity DataIC50: 0.0300nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151985BDBM151985(US8987457, 179)
Affinity DataIC50: 0.0300nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151886BDBM151886(US8987457, 80)
Affinity DataIC50: 0.0300nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151855BDBM151855(US8987457, 49)
Affinity DataIC50: 0.0300nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151987BDBM151987(US8987457, 181)
Affinity DataIC50: 0.0300nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151888BDBM151888(US8987457, 82)
Affinity DataIC50: 0.0300nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151953BDBM151953(US8987457, 147)
Affinity DataIC50: 0.0300nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151999BDBM151999(US8987457, 193)
Affinity DataIC50: 0.0300nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151867BDBM151867(US8987457, 61)
Affinity DataIC50: 0.0300nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151868BDBM151868(US8987457, 62)
Affinity DataIC50: 0.0300nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151900BDBM151900(US8987457, 94)
Affinity DataIC50: 0.0300nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151893BDBM151893(US8987457, 87)
Affinity DataIC50: 0.0300nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151894BDBM151894(US8987457, 88)
Affinity DataIC50: 0.0300nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151929BDBM151929(US8987457, 123)
Affinity DataIC50: 0.0300nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151811BDBM151811(US8987457, 5)
Affinity DataIC50: 0.0300nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151908BDBM151908(US8987457, 102)
Affinity DataIC50: 0.0300nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151936BDBM151936(US8987457, 130)
Affinity DataIC50: 0.0300nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 151872BDBM151872(US8987457, 66)
Affinity DataIC50: 0.0300nMAssay Description:Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/3/2015
Entry Details
US Patent

Displayed 1 to 50 (of 595 total ) | Next | Last >>
Jump to: